Diversifying Isoprenoid Platforms via Atypical Carbon Substrates and Non-model Microorganisms

Isoprenoid compounds are biologically ubiquitous, and their characteristic modularity has afforded products ranging from pharmaceuticals to biofuels. Isoprenoid production has been largely successful in Escherichia coli and Saccharomyces cerevisiae with metabolic engineering of the mevalonate (MVA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Carruthers, David N., Lee, Taek Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677530/
https://www.ncbi.nlm.nih.gov/pubmed/34925299
http://dx.doi.org/10.3389/fmicb.2021.791089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677530/
https://www.ncbi.nlm.nih.gov/pubmed/34925299
http://dx.doi.org/10.3389/fmicb.2021.791089

Ejemplares similares